Fatty liver is a sensitive early warning for hypertension and its complication in the Chinese population

References

• Fang JG, Zhu J, Li XJ, Li R, Dai F, Song XM, Chen L, Li F, Chen SY. Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai. Zhonghua Gan Zang Bing Za Zhi 2005;13:83–88.
   PubMedGoogle Scholar
• Trovato FM, Martines GF, Catalano D, Musumeci G, Pirri C, Trovato GM. Echocardiography and NAFLD (non-alcoholic fatty liver disease). Int J Cardiol. 2016;221:275–79. doi:10.1016/j.ijcard.2016.06.180.
   PubMed Web of Science ®Google Scholar
• Cheung O, Kapoor A, Puri P, Sistrun S, Luketic VA, Sargeant CC, Contos MJ, Shiffman ML, Stravitz RT, Sterling RK, et al. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology. 2007;46(4):1091–100. doi:10.1002/hep.21803.
   PubMed Web of Science ®Google Scholar
• Bastien M, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56(4):369–81. doi:10.1016/j.pcad.2013.10.016.
   PubMed Web of Science ®Google Scholar
• Nazare JA, Smith JD, Borel AL, Haffner SM, Balkau B, Ross R, Massien C, Alméras N, Després J-P. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am J Clin Nutr. 2012;96(4):714–26. doi:10.3945/ajcn.112.035758.
   PubMed Web of Science ®Google Scholar
• Fallo F, Dalla PA, Sonino N, Federspil G, Ermani M, Baroselli S, Catena C, Soardo G, Carretta R, Belgrado D, et al. Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients. J Hypertens. 2008;26(11):2191–97. doi:10.1097/HJH.0b013e32830dfe4b.
   PubMed Web of Science ®Google Scholar
• Chang Y, Jung HS, Cho J, Zhang Y, Yun KE, Lazo M, Pastor-Barriuso R, Ahn J, Kim C-W, Rampal S, et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am J Gastroenterol. 2016;111:1133–40.
   PubMed Web of Science ®Google Scholar
• Stolk RP, Meijer R, Mali WP, Grobbee DE, van der Graaf Y. Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am J Clin Nutr. 2003;77(4):857–60. doi:10.1093/ajcn/77.4.857.
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Barbarini G, Letizia C, Barbaro G. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring). 2014;22:332–36. doi:10.1002/oby.20624.
   PubMed Web of Science ®Google Scholar
• Vasunta RL, Kesäniemi YA, Ylitalo AS, Ukkola OH. High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults. J Hypertens. 2012;30(10):2015–19. doi:10.1097/HJH.0b013e3283576faf.
   PubMed Web of Science ®Google Scholar
• Gibby JT, Njeru DK, Cvetko ST, Merrill RM, Bikman BT, Gibby WA. Volumetric analysis of central body fat accurately predicts incidence of diabetes and hypertension in adults. BMC Obes. 2015;2:10. doi:10.1186/s40608-015-0039-3.
   PubMedGoogle Scholar
• Ye D, Dong F, Lu X, Zhang Z, Feng Y, Li C. Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division. Endocrine. 2012;42:174–81. doi:10.1007/s12020-011-9588-5.
   PubMed Web of Science ®Google Scholar
• Shirai K. Evaluation of obesity and diagnostic criteria of obesity as a disease for Japanese. Nihon Rinsho. 2001;59(3):578–85.
   PubMedGoogle Scholar
• Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53:688–708. doi:10.1016/S0008-6363(01)00527-2.
   PubMed Web of Science ®Google Scholar
• Xia MF, Yki-Järvinen H, Bian H, Lin HD, Yan HM, Chang XX, Chang -X-X, Zhou Y, Gao X. Influence of ethnicity on the accuracy of non-invasive scores predicting non-alcoholic fatty liver disease. PLoS One. 2016;11:e0160526.
   PubMed Web of Science ®Google Scholar
• Sung KC, Lee MY, Lee JY, Lee SH, Kim JY, Wild SH, Byrne CD. Resolution of fatty liver and weight loss: independent associations with changes in serum lipids and apolipoproteins. Atherosclerosis. 2018;272:47–53.
   PubMed Web of Science ®Google Scholar
• Banderas DZ, Escobedo J, Gonzalez E, Liceaga MG, Ramírez JC, Castro MG. γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. Eur J Gastroenterol Hepatol. 2012;24(7):805–10. doi:10.1097/MEG.0b013e328354044a.
   PubMed Web of Science ®Google Scholar
• Targher G, Valbusa F, Bonapace S, Bertolini L, Zenari L, Pichiri I, Mantovani A, Zoppini G, Bonora E, Barbieri E, et al. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2014;24:663–69.
   PubMed Web of Science ®Google Scholar
• Hurjui DM, Niţă O, Graur LI, Mihalache L, Popescu DS, Graur M. The central role of the non alcoholic fatty liver disease in metabolic syndrome. Rev Med Chir Soc Med Nat Iasi. 2012;116:425–31.
   PubMedGoogle Scholar
• Liu M, Wang J, Zeng J, Cao X, He Y. Association of NAFLD with diabetes and the impact of BMI changes: a 5-year cohort study based on 18,507 elderly. J Clin Endocrinol Metab. 2017;102:1309–16. doi:10.1210/jc.2016-3440.
   PubMed Web of Science ®Google Scholar
• Lallukka S, Yki-Järvinen H. Non-alcoholic fatty liver disease and risk of type 2 diabetes. Best Pract Res Clin Endocrinol Metab. 2016;30:385–95. doi:10.1016/j.beem.2016.06.006.
   PubMed Web of Science ®Google Scholar